Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation.

Conclusions: Procalcitonin does not seem to be modified by ECMO and could be a good biomarker of evolution.
PMID: 29343939 [PubMed]

Source: Biomarker Insights - January 19, 2018 Category: General Medicine Authors: Bobillo S, Rodríguez-Fanjul J, Solé A, Moreno J, Balaguer M, Esteban E, Cambra FJ, Jordan I Tags: Biomark Insights Source Type: research